Kontoor Brands, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Kontoor Brands, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Jan 2, 2021 | $2.10B | Mar 3, 2021 |
| FY2019 | Dec 28, 2019 | $652.61M | Mar 11, 2020 |
| FY2019 | Sep 28, 2019 | $638.14M | Mar 11, 2020 |
| FY2019 | Jun 29, 2019 | $609.75M | Mar 11, 2020 |
| FY2019 | Mar 30, 2019 | $648.34M | Mar 11, 2020 |
| FY2019 | Dec 29, 2018 | $726.23M | Mar 11, 2020 |
| FY2019 | Sep 29, 2018 | $704.25M | Mar 11, 2020 |
| FY2019 | Jun 30, 2018 | $663.86M | Mar 11, 2020 |
| FY2019 | Mar 31, 2018 | $669.66M | Mar 11, 2020 |
| FY2019 | Dec 30, 2017 | $2.83B | Mar 11, 2020 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 3, 2026 | $3.15B | Mar 4, 2026 |
| FY2025 | Dec 28, 2024 | $2.61B | Mar 4, 2026 |
| FY2025 | Dec 30, 2023 | $2.61B | Mar 4, 2026 |
| FY2024 | Dec 31, 2022 | $2.63B | Feb 25, 2025 |
| FY2023 | Jan 1, 2022 | $2.48B | Feb 28, 2024 |
| FY2022 | Jan 2, 2021 | $2.10B | Mar 1, 2023 |
| FY2021 | Dec 28, 2019 | $2.55B | Mar 2, 2022 |
| FY2020 | Dec 29, 2018 | $2.76B | Mar 3, 2021 |
| FY2019 | Dec 30, 2017 | $2.83B | Mar 11, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 3, 2026 | $227.45M | Mar 4, 2026 |
| FY2025 | Dec 28, 2024 | $245.80M | Mar 4, 2026 |
| FY2025 | Dec 30, 2023 | $230.99M | Mar 4, 2026 |
| FY2024 | Dec 31, 2022 | $245.49M | Feb 25, 2025 |
| FY2023 | Jan 1, 2022 | $195.42M | Feb 28, 2024 |
| FY2022 | Jan 2, 2021 | $67.92M | Mar 1, 2023 |
| FY2019 | Dec 28, 2019 | $28.75M | Mar 11, 2020 |
| FY2019 | Sep 28, 2019 | $14.50M | Mar 11, 2020 |
| FY2019 | Jun 29, 2019 | $37.99M | Mar 11, 2020 |
| FY2019 | Mar 30, 2019 | $15.41M | Mar 11, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 3, 2026 | $336.81M | Mar 4, 2026 |
| FY2025 | Dec 28, 2024 | $342.29M | Mar 4, 2026 |
| FY2025 | Dec 30, 2023 | $319.27M | Mar 4, 2026 |
| FY2024 | Dec 31, 2022 | $356.67M | Feb 25, 2025 |
| FY2023 | Jan 1, 2022 | $282.98M | Feb 28, 2024 |
| FY2022 | Jan 2, 2021 | $123.83M | Mar 1, 2023 |
| FY2019 | Dec 28, 2019 | $58.55M | Mar 11, 2020 |
| FY2019 | Sep 28, 2019 | $31.03M | Mar 11, 2020 |
| FY2019 | Jun 29, 2019 | $53.52M | Mar 11, 2020 |
| FY2019 | Mar 30, 2019 | $25.20M | Mar 11, 2020 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 3, 2026 | $1.09B | Mar 4, 2026 |
| FY2025 | Dec 28, 2024 | $819.28M | Mar 4, 2026 |
| FY2025 | Dec 30, 2023 | $768.57M | Mar 4, 2026 |
| FY2024 | Dec 31, 2022 | $777.70M | Feb 25, 2025 |
| FY2023 | Jan 1, 2022 | $824.75M | Feb 28, 2024 |
| FY2022 | Jan 2, 2021 | $739.86M | Mar 1, 2023 |
| FY2021 | Dec 28, 2019 | $803.45M | Mar 2, 2022 |
| FY2020 | Dec 29, 2018 | $781.52M | Mar 3, 2021 |
| FY2019 | Dec 30, 2017 | $814.54M | Mar 11, 2020 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 3, 2026 | $455.81M | Mar 4, 2026 |
| FY2025 | Dec 28, 2024 | $368.23M | Mar 4, 2026 |
| FY2025 | Dec 30, 2023 | $356.55M | Mar 4, 2026 |
| FY2024 | Dec 31, 2022 | $83.59M | Feb 25, 2025 |
| FY2023 | Jan 1, 2022 | $283.86M | Feb 28, 2024 |
| FY2022 | Jan 2, 2021 | $241.97M | Mar 1, 2023 |
| FY2021 | Dec 28, 2019 | $777.79M | Mar 2, 2022 |
| FY2020 | Dec 29, 2018 | ($96.30M) | Mar 3, 2021 |
| FY2019 | Dec 30, 2017 | $168.60M | Mar 11, 2020 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 3, 2026 | $21.05M | Mar 4, 2026 |
| FY2025 | Dec 28, 2024 | $18.79M | Mar 4, 2026 |
| FY2025 | Dec 30, 2023 | $27.37M | Mar 4, 2026 |
| FY2024 | Dec 31, 2022 | $18.38M | Feb 25, 2025 |
| FY2023 | Jan 1, 2022 | $10.55M | Feb 28, 2024 |
| FY2022 | Jan 2, 2021 | $18.18M | Mar 1, 2023 |
| FY2021 | Dec 28, 2019 | $22.68M | Mar 2, 2022 |
| FY2020 | Dec 29, 2018 | $21.04M | Mar 3, 2021 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 3, 2026 | $2.58B | Mar 4, 2026 |
| FY2025 | Dec 28, 2024 | $1.65B | Mar 4, 2026 |
| FY2024 | Dec 30, 2023 | $1.65B | Feb 25, 2025 |
| FY2023 | Dec 31, 2022 | $1.58B | Feb 28, 2024 |
| FY2022 | Jan 1, 2022 | $1.53B | Mar 1, 2023 |
| FY2021 | Jan 2, 2021 | $1.55B | Mar 2, 2022 |
| FY2020 | Dec 28, 2019 | $1.52B | Mar 3, 2021 |
| FY2019 | Dec 29, 2018 | $2.46B | Mar 11, 2020 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 3, 2026 | $2.02B | Mar 4, 2026 |
| FY2025 | Dec 28, 2024 | $1.25B | Mar 4, 2026 |
| FY2024 | Dec 30, 2023 | $1.27B | Feb 25, 2025 |
| FY2023 | Dec 31, 2022 | $1.33B | Feb 28, 2024 |
| FY2022 | Jan 1, 2022 | $1.38B | Mar 1, 2023 |
| FY2021 | Jan 2, 2021 | $1.46B | Mar 2, 2022 |
| FY2020 | Dec 28, 2019 | $1.45B | Mar 3, 2021 |
| FY2019 | Dec 29, 2018 | $735.01M | Mar 11, 2020 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 3, 2026 | $564.87M | Mar 4, 2026 |
| FY2025 | Dec 28, 2024 | $400.06M | Mar 4, 2026 |
| FY2025 | Dec 30, 2023 | $371.91M | Mar 4, 2026 |
| FY2025 | Dec 31, 2022 | $250.76M | Mar 4, 2026 |
| FY2024 | Jan 1, 2022 | $148.14M | Feb 25, 2025 |
| FY2023 | Jan 2, 2021 | $84.64M | Feb 28, 2024 |
| FY2022 | Dec 28, 2019 | $69.26M | Mar 1, 2023 |
| FY2021 | Dec 29, 2018 | $1.72B | Mar 2, 2022 |
| FY2020 | Dec 30, 2017 | $1.36B | Mar 3, 2021 |
| FY2019 | Dec 31, 2016 | $1.39B | Mar 11, 2020 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 3, 2026 | $531.14M | Mar 4, 2026 |
| FY2025 | Dec 28, 2024 | $208.79M | Mar 4, 2026 |
| FY2025 | Dec 30, 2023 | $209.86M | Mar 4, 2026 |
| FY2024 | Dec 31, 2022 | $209.63M | Feb 25, 2025 |
| FY2023 | Jan 1, 2022 | $212.21M | Feb 28, 2024 |
| FY2022 | Jan 2, 2021 | $213.39M | Mar 1, 2023 |
| FY2021 | Dec 28, 2019 | $212.84M | Mar 2, 2022 |
| FY2020 | Dec 29, 2018 | $214.52M | Mar 3, 2021 |
| FY2019 | Dec 30, 2017 | $219.29M | Mar 11, 2020 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 3, 2026 | $274.28M | Mar 4, 2026 |
| FY2025 | Dec 28, 2024 | $199.96M | Mar 4, 2026 |
| FY2024 | Dec 30, 2023 | $166.57M | Feb 25, 2025 |
| FY2023 | Dec 31, 2022 | $86.73M | Feb 28, 2024 |
| FY2022 | Jan 1, 2022 | $22.64M | Mar 1, 2023 |
| FY2021 | Jan 2, 2021 | $7.15M | Mar 2, 2022 |
| FY2020 | Dec 28, 2019 | ($1.72M) | Mar 3, 2021 |
| FY2019 | Dec 29, 2018 | $0 | Mar 11, 2020 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 3, 2026 | $108.44M | Mar 4, 2026 |
| FY2025 | Dec 28, 2024 | $334.07M | Mar 4, 2026 |
| FY2024 | Dec 30, 2023 | $215.05M | Feb 25, 2025 |
| FY2023 | Dec 31, 2022 | $59.18M | Feb 28, 2024 |
| FY2022 | Jan 1, 2022 | $185.32M | Mar 1, 2023 |
| FY2021 | Jan 2, 2021 | $248.14M | Mar 2, 2022 |
| FY2020 | Dec 28, 2019 | $106.81M | Mar 3, 2021 |
| FY2019 | Dec 29, 2018 | $96.78M | Mar 11, 2020 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 3, 2026 | $1.14B | Mar 4, 2026 |
| FY2025 | Dec 28, 2024 | $740.32M | Mar 4, 2026 |
| FY2024 | Dec 30, 2023 | $783.92M | Feb 25, 2025 |
| FY2023 | Dec 31, 2022 | $792.62M | Feb 28, 2024 |
| FY2022 | Jan 1, 2022 | $791.32M | Mar 1, 2023 |
| FY2021 | Jan 2, 2021 | $912.96M | Mar 2, 2022 |
| FY2020 | Dec 28, 2019 | $913.27M | Mar 3, 2021 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 3, 2026 | 4 | Mar 4, 2026 |
| FY2025 | Dec 28, 2024 | 4 | Mar 4, 2026 |
| FY2025 | Dec 30, 2023 | 4 | Mar 4, 2026 |
| FY2024 | Dec 31, 2022 | 4 | Feb 25, 2025 |
| FY2023 | Jan 1, 2022 | 3 | Feb 28, 2024 |
| FY2022 | Jan 2, 2021 | 1 | Mar 1, 2023 |
| FY2021 | Dec 28, 2019 | 1 | Mar 2, 2022 |
| FY2020 | Dec 29, 2018 | 4 | Mar 3, 2021 |
| FY2019 | Dec 30, 2017 | 2 | Mar 11, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 3, 2026 | 4 | Mar 4, 2026 |
| FY2025 | Dec 28, 2024 | 4 | Mar 4, 2026 |
| FY2025 | Dec 30, 2023 | 4 | Mar 4, 2026 |
| FY2024 | Dec 31, 2022 | 4 | Feb 25, 2025 |
| FY2023 | Jan 1, 2022 | 3 | Feb 28, 2024 |
| FY2022 | Jan 2, 2021 | 1 | Mar 1, 2023 |
| FY2021 | Dec 28, 2019 | 1 | Mar 2, 2022 |
| FY2020 | Dec 29, 2018 | 4 | Mar 3, 2021 |
| FY2019 | Dec 30, 2017 | 2 | Mar 11, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 3, 2026 | 55.24M | Mar 4, 2026 |
| FY2025 | Dec 28, 2024 | 55.31M | Mar 4, 2026 |
| FY2024 | Dec 30, 2023 | 55.72M | Feb 25, 2025 |
| FY2023 | Dec 31, 2022 | 55.52M | Feb 28, 2024 |
| FY2022 | Jan 1, 2022 | 56.38M | Mar 1, 2023 |
| FY2021 | Jan 2, 2021 | 57.25M | Mar 2, 2022 |
| FY2020 | Dec 28, 2019 | 56.81M | Mar 3, 2021 |
| FY2019 | Dec 29, 2018 | 0 | Mar 11, 2020 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 3, 2026 | $116.09M | Mar 4, 2026 |
| FY2025 | Dec 28, 2024 | $112.06M | Mar 4, 2026 |
| FY2025 | Dec 30, 2023 | $108.57M | Mar 4, 2026 |
| FY2024 | Dec 31, 2022 | $103.66M | Feb 25, 2025 |
| FY2023 | Jan 1, 2022 | $95.08M | Feb 28, 2024 |
| FY2022 | Jan 2, 2021 | $54.77M | Mar 1, 2023 |
| FY2021 | Dec 28, 2019 | $63.56M | Mar 2, 2022 |
| FY2020 | Dec 29, 2018 | $0 | Mar 3, 2021 |
| FY2019 | Dec 30, 2017 | $0 | Mar 11, 2020 |